FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns medicine and pharmacology, particularly a solid dosed formulation for treatment of pancreatic diabetes, the said formulation including a highly stable and solid combination of therapeutically effective quantities of metformin and glyclazide at the ratio of 6.2-12.5 with target additives such as sorbitol, polyvinylpyrrolidone, stearic acid and/or stearate, sodium croscarmellose as active substance.
EFFECT: obtaining solid formulation for treatment of pancreatic diabetes.
4 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID UNIT DOSAGE FORM FOR PANCREATIC DIABETES | 2009 |
|
RU2380097C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
| PHARMACEUTICAL COMPOSITION WITH SUSTAINED-RELEASE OF GLICLAZIDE | 2004 |
|
RU2273482C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT AND METHOD OF ITS PREPARING | 2000 |
|
RU2177318C1 |
| SOLID DOSED MEDICINAL FORMULATION FOR ORAL USING CONTAINING COMBINATION OF METFORMIN AND GLIBENCLAMIDE | 1999 |
|
RU2226396C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES (VERSIONS) | 2010 |
|
RU2483717C2 |
| SOLID DOZED PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING COMBINATION OF METFORMIN AND GLIBENCLAMIDE | 1999 |
|
RU2286788C2 |
| ANTI-DIABETIC PREPARATION AND METHOD FOR TREATMENT OF DIABETES MELLITUS | 2000 |
|
RU2276604C2 |
